Business | Press Trust of India | Friday June 3, 2016
Natco Pharma shares surged nearly 9 per cent on Friday after the company said its marketing partner Mylan Inc has received tentative approval from the US health regulator for selling generic Sorafenib tablets, used for cancer treatment, in the American market.
www.ndtv.com/business